News
-
-
REGULATED PRESS RELEASE
EURAZEO SIGNS EZORE FUND’S FIRST TRANSACTION WITH ACQUISITION OF AQUARDENS, ITALY’S LARGEST THERMAL PARK
Eurazeo's first transaction through EZORE fund: acquisition of Aquardens, Italy's largest thermal park, to enhance customer offerings and drive sustainability, marking the debut of the innovative investment strategy -
REGULATED PRESS RELEASE
Disclosure of transactions in own shares from February 17 to February 21, 2025
-
REGULATED PRESS RELEASE
Disclosure of transactions in own shares from February 10 to February 14, 2025
-
-
REGULATED PRESS RELEASE
EURAZEO PARTICIPATES IN GERMITEC’S EUR 29 MILLION SERIES B FUNDRAISING
Eurazeo participates in Germitec’s €29 million Series B fundraising to support the development of innovative High-Level Disinfection solutions for ultrasound probes. Nov Santé Actions Non Cotées is the lead investor -
-
REGULATED PRESS RELEASE
Disclosure of the number of shares and the total number of voting rights as of January 31, 2025
Eurazeo discloses total shares and voting rights. Leading European investment group with diverse assets of 35.5 billion euros, focusing on private equity, private debt, real estate, and infrastructure -
REGULATED PRESS RELEASE
Disclosure of transactions in own shares from February 3 to February 7, 2025
-
REGULATED PRESS RELEASE
Disclosure of transactions in own shares from January 27 to January 31, 2025
